EPG Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
EPG Wealth Management's PFE Position: Q4 2023 in Review
EPG Wealth Management sold out of Pfizer (PFE) in Q4 2023, closing a stake of 15,259 shares — an estimated $506K sold.
EPG Wealth Management first reported a position in PFE in Q4 2019 and held it in 14 quarters. The position peaked at $766K in Q2 2022. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.
- EPG Wealth Management reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
- EPG Wealth Management sold 15,259 Pfizer shares in Q4 2023, an estimated $506K.
- EPG Wealth Management first reported a position in Pfizer in Q4 2019 and held it in 14 quarters.
- EPG Wealth Management's Pfizer position peaked at $766K in Q2 2022.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.
Based on EPG Wealth Management's 13F filing for Q4 2023, filed 15 Feb 2024.